INCR - MCAP CO - InterCure Ltd.

InterCure Ltd. (INCR) is a leading Israeli operator specializing in the delivery of specialty pharmaceuticals, where diversified raw material supplies minimize political risks. Strict climate control and secure transportation of botanical products ensure compliance with all medical regulations. The company's price chart on the GURU.Markets platform shows a market capitalization of 0.05. Stable cash flow from its pharmacy network and cannabis production ensures sustainable business growth.

Market capitalization reflects the aggregate value of all shares, weighing current investor expectations against the actual scale of the business. This metric serves as a tool for stress-testing shareholder value during periods of macroeconomic instability. Analyzing the total capitalization of a public company allows for an assessment of the asset's resilience to market shocks. For InterCure Ltd. (INCR), this indicator is supported by vertical integration spanning from cultivation to pharmacies. Supply chain diversification minimizes risks, sustaining the fundamental capacity of the business.